Literature DB >> 7448158

Antibodies to lens antigens in cataract and after cataract surgery.

S H Nissen, P Andersen, H M Andersen.   

Abstract

By means of an enzyme-linked immunosorbent assay (ELISA) antibodies to whole lens homogenate were found in 50.0% of 38 patients with senile cataract and in 57.3% of 75 controls. The antibody titres were in the range of 10-160 in both groups. IgG antibodies occurred in 44.7% of patients and in 45.3% of controls, whereas IgM antibodies were found in 21.1% of the patients and in 40.0% of the controls (not significant). Postoperative uveitis occurred in 5 (31.6%) of 19 patients, who had antibodies in serum prior to the operation and in only 2 (10.5%) of 19 antibody-negative patients (P = 0.10).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7448158      PMCID: PMC1039415          DOI: 10.1136/bjo.65.1.63

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Incidence and titers of antinuclear, antismooth muscle, and other autoantibodies in blood donors.

Authors:  S Shu; R J Nisengard; W L Hale; E H Beutner
Journal:  J Lab Clin Med       Date:  1975-08

2.  Enzyme immunoassays in diagnostic medicine. Theory and practice.

Authors:  A Voller; D E Bidwell; A Bartlett
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

3.  ANTI-LENS ANTIBODY IN HUMAN SERA.

Authors:  E HACKETT; A THOMPSON
Journal:  Lancet       Date:  1964-09-26       Impact factor: 79.321

4.  AUTO-IMMUNITY IN UVEITIS.

Authors:  E S PERKINS; R M WOOD
Journal:  Br J Ophthalmol       Date:  1964-02       Impact factor: 4.638

5.  Correlation of smooth-muscle and nuclear antibodies in normal subjects.

Authors:  P Andersen
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

6.  Lens-induced uveitis.

Authors:  E Wirostko; H F Spalter
Journal:  Arch Ophthalmol       Date:  1967-07

7.  Anti-uveal and anti-lens antibodies in uveitis and their significance.

Authors:  M H Luntz
Journal:  Exp Eye Res       Date:  1968-10       Impact factor: 3.467

8.  The humoral immune response to alpha, beta and gamma crystallins of the human lens.

Authors:  H O Sandberg; O Closs
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

9.  Immunopathology of the lens. III. Humoral and cellular immune responses to autologous lens antigens and their roles in ocular inflammation.

Authors:  A H Rahi; R N Misra; G Morgan
Journal:  Br J Ophthalmol       Date:  1977-06       Impact factor: 4.638

10.  Homologous immunological studies of ocular lens. II. Biological aspects.

Authors:  S P HALBERT; D LOCATCHER-KHORAZO; L SWICK; R WITMER; B SEEGAL; P FITZGERALD
Journal:  J Exp Med       Date:  1957-05-01       Impact factor: 14.307

View more
  5 in total

1.  Phacolytic glaucoma and lens-induced uveitis.

Authors:  J C Filipe; J Palmares; L Delgado; J M Lopes; J Borges; J Castro-Correia
Journal:  Int Ophthalmol       Date:  1993-10       Impact factor: 2.031

2.  Antilens antibodies in cataract and inflammatory eye disease: an evaluation of a new technique.

Authors:  M Patel; B Shine; P I Murray
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

3.  Characterization of anti-crystallin autoantibodies in patients with cataract.

Authors:  K B Merck; W A de Haard-Hoekman; J R Cruysberg; H Bloemendal; W W de Jong
Journal:  Mol Biol Rep       Date:  1993-02       Impact factor: 2.316

4.  High incidence of antibodies to lens proteins in sera from patients with uveitis.

Authors:  Deshka Doycheva; Doycheva Deshka; Beate Preuss; Preuss Beate; Reinhild Klein; Klein Reinhild; Manfred Zierhut; Zierhut Manfred
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-09-19       Impact factor: 3.535

5.  Immunochemical detection of glycated lens crystallins and their circulating autoantibodies in human serum during aging.

Authors:  Mala Ranjan; Sujatha Nayak; Tanuja Kosuri; Beedu Sashidhar Rao
Journal:  Mol Vis       Date:  2008-11-17       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.